Abstract
L-asparaginase is an important therapeutic biomolecule, used to treat lymphocytic leukemia. In the present study, Iodobacter sp. PCH194 genome was mined for new L-asparaginase (Id-ASNase II). In silico analysis including amino acid composition and pI revealed its sequence-based novelty and phylogenetic closeness to the commercial bacterial L-asparaginases. Subsequently, the gene was successfully cloned and overexpressed in Escherichia coli (E. coli BL21 DE3). The monomeric molecular weight of Id-ASNase II was 38 kDa with a native size of 150 kDa. Maximum L-asparaginase activity (80 U mg− 1) was achieved in 25 mM Tris-HCl buffer (pH 8.2) at 37 °C after 10 min of incubation. The enzyme was active in wide pH (5.0–11.0) and temperature ranges (4–70 °C). The half-life (t1/2) of the enzyme at 37 °C was 13.54 h, whereas Km, Vmax, kcat, and kcat/Km were 1.2 mM, 128 µmoles min− 1, 82 s− 1, and 63.1 s− 1 mM− 1, respectively. Id-ASNase II exhibited cytotoxicity against cancer cell line K562 (IC50 value 0.4 U mL− 1) leading to cell cycle arrest in the G2/M phase after treatment. Furthermore, 10 U Id-ASNase II led to a 57% acrylamide reduction in potato chips. Thus, the study discovered and characterized Id-ASNase II with potential applications for treating leukemia and food processing.
Original language | English |
---|---|
Journal | Biologia |
ISSN | 0006-3088 |
DOIs | |
Publication status | Accepted/In press - 2024 |
Bibliographical note
Publisher Copyright:© The Author(s), under exclusive licence to Plant Science and Biodiversity Centre, Slovak Academy of Sciences (SAS), Institute of Zoology, Slovak Academy of Sciences (SAS), Institute of Molecular Biology, Slovak Academy of Sciences (SAS) 2024.
Keywords
- Acrylamide mitigation
- Cytotoxicity
- Iodobacter sp. PCH194
- L-asparaginase